EI
GILD icon

Ethic Inc’s Gilead Sciences GILD Stock Holding History

Ethic Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Buy
85,798
+5,679
+7% +$795K 0.19% 108
2025
Q4 		$9.83M Buy
80,119
+3,103
+4% +$377K 0.15% 130
2025
Q3 		$8.55M Buy
77,016
+1,923
+3% +$219K 0.14% 151
2025
Q2 		$8.31M Buy
75,093
+3,821
+5% +$407K 0.15% 146
2025
Q1 		$7.93M Sell
71,272
-33,372
-32% -$3.44M 0.16% 134
2024
Q4 		$9.67M Buy
104,644
+7,638
+8% +$688K 0.2% 100
2024
Q3 		$7.11M Buy
97,006
+7,482
+8% +$571K 0.18% 120
2024
Q2 		$6.14M Sell
89,524
-7,482
-8% -$499K 0.14% 149
2024
Q1 		$7.11M Sell
97,006
-15,772
-14% -$1.21M 0.18% 120
2023
Q4 		$9.14M Buy
112,778
+4,423
+4% +$344K 0.27% 74
2023
Q3 		$8.12M Buy
108,355
+7,508
+7% +$577K 0.28% 72
2023
Q2 		$7.77M Buy
100,847
+5,808
+6% +$463K 0.29% 71
2023
Q1 		$7.89M Buy
95,039
+31,117
+49% +$2.58M 0.32% 62
2022
Q4 		$5.49M Buy
63,922
+19,028
+42% +$1.51M 0.3% 77
2022
Q3 		$2.77M Buy
44,894
+13,979
+45% +$881K 0.19% 133
2022
Q2 		$1.91M Buy
30,915
+3,895
+14% +$241K 0.13% 200
2022
Q1 		$1.61M Sell
27,020
-3,626
-12% -$232K 0.11% 240
2021
Q4 		$2.23M Sell
30,646
-12,477
-29% -$859K 0.17% 145
2021
Q3 		$3.01M Sell
43,123
-6,690
-13% -$470K 0.31% 75
2021
Q2 		$3.43M Buy
49,813
+15,969
+47% +$1.07M 0.42% 48
2021
Q1 		$2.19M Buy
33,844
+14,567
+76% +$939K 0.39% 53
2020
Q4 		$1.12M Buy
19,277
+4,419
+30% +$267K 0.3% 82
2020
Q3 		$939K Buy
14,858
+3,772
+34% +$262K 0.36% 63
2020
Q2 		$853K Buy
11,086
+1,446
+15% +$111K 0.49% 46
2020
Q1 		$721K Buy
9,640
+1,878
+24% +$130K 0.6% 46
2019
Q4 		$504K Buy
+7,762
New +$505K 0.37% 89

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ethic Inc's GILD Position: Q1 2026 in Review

Ethic Inc increased its Gilead Sciences (GILD) stake by 7.1% in Q1 2026, buying an estimated $795K and bringing the position to 85,798 shares worth $12M. The position accounts for 0.19% of the portfolio, ranked #108.

Ethic Inc first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ethic Inc held 85,798 shares of Gilead Sciences worth $12M as of Q1 2026.
  • Ethic Inc bought 5,679 Gilead Sciences shares in Q1 2026, an estimated $795K.
  • Gilead Sciences made up 0.19% of Ethic Inc's portfolio in Q1 2026, its #108 holding.
  • Ethic Inc first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.